Bovie Medical Corporation to Release First Quarter 2017 Financial Results on May 15, 2017
April 26 2017 - 5:09PM
Business Wire
Bovie Medical (NYSE MKT: BVX), a maker of medical
devices and supplies and the developer of J-Plasma®, a patented new
surgical product, today announced that financial results for the
first quarter of 2017 will be released after the market closes on
Monday, May 15.
Management will host a conference call at 4:30 p.m. Eastern Time
on May 15 to discuss the results of the quarter and host a question
and answer session. To listen to the call by phone, interested
parties within the U.S. may dial 866-682-6100. International
callers may dial 862-255-5401. Participants should ask for the
Bovie Medical Corporation Call. A live webcast of the call will be
accessible via the Investor Relations section of the Company’s
website and
at: http://www.investorcalendar.com/IC/CEPage.asp?ID=175894.
A telephonic replay will be available approximately two hours
after the end of the call through June 15, 2017. The replay can be
accessed by dialing 877-481-4010 for U.S. callers or 919-882-2331
for International callers and using the replay access code: 10357.
The webcast will be archived on the Investor Relations section of
the Company's website.
About Bovie Medical Corporation
Bovie Medical Corporation is a leading maker of medical devices
and supplies as well as the developer of J-Plasma®, a patented
plasma-based surgical product for cutting and coagulation.
J-Plasma® utilizes a helium ionization process to produce a
stable, focused beam of ionized gas that provides surgeons with
greater precision, minimal invasiveness and an absence of
conductive currents through the patient during surgery. Bovie
Medical Corporation is also a leader in the manufacture of a range
of electrosurgical products and technologies, marketed through both
private labels and the Company’s own well-respected brands (Bovie®,
IDS™, ICON™ and DERMTM) to distributors worldwide. The Company also
leverages its expertise through original equipment manufacturing
(OEM) agreements with other medical device manufacturers. For
further information about the Company’s current and new products,
please refer to the Investor Relations section of Bovie Medical
Corporation at www.boviemed.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170426006764/en/
Investor Relations:Westwicke PartnersMike Piccinino,
CFAManaging Director443-213-0500investor.relations@boviemed.com
Bovie (AMEX:BVX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bovie (AMEX:BVX)
Historical Stock Chart
From Sep 2023 to Sep 2024